… Denali Therapeutics, UCB and BMS. He has worked on multiple Parkinson’s programs, including GBA, LRRK2, …

… at Brooklyn, scientific program manager at the National Multiple Sclerosis Society, and manager of Biomedical …

… in PD. To overcome translational limitations, he utilizes multiple in vivo models to test hypotheses. …

… provides patient care using a multidisciplinary approach. Multiple clinical trials are conducted under this flagship. …

… imaging scans, a tool for assessing dopamine transporter system dysfunction and thereby Parkinson’s pathology, … alpha-synuclein, such as Dementia with Lewy Bodies (DLB) or Multiple System Atrophy (MSA). The test, on its own, cannot differentiate …

… target for PD research. LRRK-2 is a large protein with multiple functional domains, including a protein kinase … has well-recognized expertise in this approach, having multiple ongoing kinase inhibitor programs in several …